Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review
Crossref DOI link: https://doi.org/10.1007/s12325-020-01319-9
Published Online: 2020-04-21
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Martin, Vincent
Samaan, Karen Hamrick
Aurora, Sheena
Pearlman, Eric M.
Zhou, Chunmei
Li, Xiaoping
Pallay, Robert
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2020-04-21
Version of Record valid from 2020-04-21
Article History
Received: 17 December 2019
First Online: 21 April 2020